2.16 USD
↘ 0.11 (4.85%)AT CLOSE (11:59 AM EDT)
Radiopharm Theranostics Limited American Depositary Shares
RADXNASDAQ • USD
2.12
↘ 0.04 (1.67%)
POST MARKET (AS OF 05:05 PM EDT)
Post Market
AS OF 05:05 PM EDT
2.12
↘ 0.04 (1.67%)
Market: CLOSED
RADX is currently priced at $2.21. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Sep 2, 2026.
Open?$2.27
High?$2.30
Low?$2.05
Prev. Close?$2.27
Volume?11.0K
Avg. Volume?N/A
VWAP?$2.16
Bid / Ask
Bid?$1.72 × 100
Ask?$2.58 × 100
Spread?$0.86
Midpoint?$2.15
Valuation & Ratios
Market Cap?32.8M
Shares Out?14.5M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short Interest?27.0K
Days to Cover?1.0
Avg Daily Volume50.7K
Settlement Date2026-08-14